Please enable JavaScript to continue using this application.

Compare $SNDX vs $XNCR | Chartloom

Compare

$SNDX vs $XNCR

Syndax Pharmaceuticals Inc · Xencor Inc

SNDX

Syndax Pharmaceuticals Inc

XNCR

Xencor Inc

Compare $SNDX vs $XNCR

Comparing Syndax Pharmaceuticals Inc and Xencor Inc

SNDXSyndax Pharmaceuticals Inc

XNCRXencor Inc

SNDXSyndax Pharmaceuticals Inc

Market cap

$1.51B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

222.7%

YTD performance

-20.2%

52W performance

3.0%

FCF yield

-14.7%

XNCRXencor Inc

Market cap

$1.83B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.26x

Rev growth (TTM)

-33.2%

YTD performance

65.1%

52W performance

98.6%

FCF yield

-11.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SNDX

XNCR

Detailed metrics comparison

SNDX

Syndax Pharmaceuticals Inc

XNCR

Xencor Inc

Market Cap

SNDX$1.51B

XNCR$1.83B

Enterprise Value

SNDX$1.76B

XNCR$1.89B

Price

SNDX$16.99

XNCR$24.63

P/E Ratio

SNDXN/A

XNCRN/A

P/S Ratio

SNDX5.97x

XNCR17.40x

EV/Sales

SNDX6.97x

XNCR17.97x

EV/EBITDA

SNDX1,613.51x

XNCR31.73x

P/B Ratio

SNDX104.09x

XNCR3.71x

P/FCF Ratio

SNDXN/A

XNCRN/A

EV/FCF

SNDX-7.96x

XNCR-9.06x

PEG Ratio

SNDXN/A

XNCRN/A

Forward P/E (NTM)

SNDXN/A

XNCRN/A

Forward P/S (NTM)

SNDXN/A

XNCR14.26x

Revenue (TTM)

SNDX$252M

XNCR$105M

Revenue Growth (YoY)

SNDX222.7%

XNCR-33.2%

Forward Rev Growth

SNDX41.0%

XNCR7.4%

Gross Margin (TTM)

SNDX95.8%

XNCR0.0%

Operating Margin (TTM)

SNDX0.0%

XNCR0.0%

EBITDA Margin (TTM)

SNDX-77.0%

XNCR-188.5%

Net Margin (TTM)

SNDX-87.5%

XNCR-155.6%

FCF Margin (TTM)

SNDX-87.6%

XNCR-198.4%

Net Income (TTM)

SNDX$-221M

XNCR$-163M

FCF (TTM)

SNDX$-221M

XNCR$-208M

EPS (TTM)

SNDX-$2.48

XNCR-$2.15

ROE (TTM)

SNDX-37294.0%

XNCR-2866.0%

ROA (TTM)

SNDX-3911.0%

XNCR-2038.0%

ROIC (TTM)

SNDX-4756.0%

XNCR-2379.0%

Cash

SNDX$336M

XNCR$45M

Debt

SNDX$588M

XNCR$105M

Net Cash/Debt

SNDX$-252M

XNCR$-60M

Current Ratio (TTM)

SNDX6.77x

XNCR6.39x

Quick Ratio (TTM)

SNDX6.32x

XNCR6.09x

Debt/Equity (TTM)

SNDX38.95x

XNCR0.21x

Debt/Assets (TTM)

SNDX0.0%

XNCR0.0%

Interest Coverage (TTM)

SNDXN/A

XNCRN/A

Net Debt/EBITDA (TTM)

SNDX0.00x

XNCR0.00x

Beta

SNDX0.40

XNCR0.81

52W Performance

SNDX3.0%

XNCR98.6%

YTD Performance

SNDX-20.2%

XNCR65.1%

% from 52W High

SNDX-33.6%

XNCR-19.5%

% from 52W Low

SNDX30.8%

XNCR137.4%

Asset Turnover (TTM)

SNDX0.45x

XNCR0.13x

FCF Yield (TTM)

SNDX-14.7%

XNCR-11.4%

Earnings Yield (TTM)

SNDX-14.7%

XNCR-8.9%

Dividend Yield (TTM)

SNDXN/A

XNCRN/A

Rule of 40

SNDX135.1

XNCR-231.6

EV/GP/RG

SNDX0.15

XNCRN/A

Ticker research

View SNDX research View XNCR research

Metric	SNDX Syndax Pharmaceuticals Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.51B	$1.83B
Enterprise Value	$1.76B	$1.89B
Price	$16.99	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	5.97x	17.40x
EV/Sales	6.97x	17.97x
EV/EBITDA	1,613.51x	31.73x
P/B Ratio	104.09x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.96x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.26x
Revenue & Growth
Revenue (TTM)	$252M	$105M
Revenue Growth (YoY)	222.7%	-33.2%
Forward Rev Growth	41.0%	7.4%
Profitability
Gross Margin (TTM)	95.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-77.0%	-188.5%
Net Margin (TTM)	-87.5%	-155.6%
FCF Margin (TTM)	-87.6%	-198.4%
Net Income (TTM)	$-221M	$-163M
FCF (TTM)	$-221M	$-208M
EPS (TTM)	-$2.48	-$2.15
ROE (TTM)	-37294.0%	-2866.0%
ROA (TTM)	-3911.0%	-2038.0%
ROIC (TTM)	-4756.0%	-2379.0%
Financial Health
Cash	$336M	$45M
Debt	$588M	$105M
Net Cash/Debt	$-252M	$-60M
Current Ratio (TTM)	6.77x	6.39x
Quick Ratio (TTM)	6.32x	6.09x
Debt/Equity (TTM)	38.95x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.40	0.81
52W Performance	3.0%	98.6%
YTD Performance	-20.2%	65.1%
% from 52W High	-33.6%	-19.5%
% from 52W Low	30.8%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.13x
FCF Yield (TTM)	-14.7%	-11.4%
Earnings Yield (TTM)	-14.7%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	135.1	-231.6
EV/GP/RG	0.15	N/A
Ticker research	View SNDX research	View XNCR research

Valuation

P/S Ratio

SNDX

5.97x

XNCR

17.40x

EV/FCF

XNCR

-9.06x

SNDX

-7.96x

Growth & revenue

Revenue Growth TTM

SNDX

222.7%

XNCR

-33.2%

Forward Revenue Growth

SNDX

41.0%

XNCR

7.4%

Profitability & performance

Gross Margin

SNDX

95.8%

XNCR

0.0%

ROE

XNCR

-2866.0%

SNDX

-37294.0%

FCF Yield %

XNCR

-11.4%

SNDX

-14.7%

52-Week Performance

XNCR

98.6%

SNDX

3.0%

Detailed metrics comparison

SNDX

Syndax Pharmaceuticals Inc

XNCR

Xencor Inc

Market Cap

SNDX$1.51B

XNCR$1.83B

Enterprise Value

SNDX$1.76B

XNCR$1.89B

Price

SNDX$16.99

XNCR$24.63

P/E Ratio

SNDXN/A

XNCRN/A

P/S Ratio

SNDX5.97x

XNCR17.40x

EV/Sales

SNDX6.97x

XNCR17.97x

EV/EBITDA

SNDX1,613.51x

XNCR31.73x

P/B Ratio

SNDX104.09x

XNCR3.71x

P/FCF Ratio

SNDXN/A

XNCRN/A

EV/FCF

SNDX-7.96x

XNCR-9.06x

PEG Ratio

SNDXN/A

XNCRN/A

Forward P/E (NTM)

SNDXN/A

XNCRN/A

Forward P/S (NTM)

SNDXN/A

XNCR14.26x

Revenue (TTM)

SNDX$252M

XNCR$105M

Revenue Growth (YoY)

SNDX222.7%

XNCR-33.2%

Forward Rev Growth

SNDX41.0%

XNCR7.4%

Gross Margin (TTM)

SNDX95.8%

XNCR0.0%

Operating Margin (TTM)

SNDX0.0%

XNCR0.0%

EBITDA Margin (TTM)

SNDX-77.0%

XNCR-188.5%

Net Margin (TTM)

SNDX-87.5%

XNCR-155.6%

FCF Margin (TTM)

SNDX-87.6%

XNCR-198.4%

Net Income (TTM)

SNDX$-221M

XNCR$-163M

FCF (TTM)

SNDX$-221M

XNCR$-208M

EPS (TTM)

SNDX-$2.48

XNCR-$2.15

ROE (TTM)

SNDX-37294.0%

XNCR-2866.0%

ROA (TTM)

SNDX-3911.0%

XNCR-2038.0%

ROIC (TTM)

SNDX-4756.0%

XNCR-2379.0%

Cash

SNDX$336M

XNCR$45M

Debt

SNDX$588M

XNCR$105M

Net Cash/Debt

SNDX$-252M

XNCR$-60M

Current Ratio (TTM)

SNDX6.77x

XNCR6.39x

Quick Ratio (TTM)

SNDX6.32x

XNCR6.09x

Debt/Equity (TTM)

SNDX38.95x

XNCR0.21x

Debt/Assets (TTM)

SNDX0.0%

XNCR0.0%

Interest Coverage (TTM)

SNDXN/A

XNCRN/A

Net Debt/EBITDA (TTM)

SNDX0.00x

XNCR0.00x

Beta

SNDX0.40

XNCR0.81

52W Performance

SNDX3.0%

XNCR98.6%

YTD Performance

SNDX-20.2%

XNCR65.1%

% from 52W High

SNDX-33.6%

XNCR-19.5%

% from 52W Low

SNDX30.8%

XNCR137.4%

Asset Turnover (TTM)

SNDX0.45x

XNCR0.13x

FCF Yield (TTM)

SNDX-14.7%

XNCR-11.4%

Earnings Yield (TTM)

SNDX-14.7%

XNCR-8.9%

Dividend Yield (TTM)

SNDXN/A

XNCRN/A

Rule of 40

SNDX135.1

XNCR-231.6

EV/GP/RG

SNDX0.15

XNCRN/A

Ticker research

View SNDX research View XNCR research

Metric	SNDX Syndax Pharmaceuticals Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.51B	$1.83B
Enterprise Value	$1.76B	$1.89B
Price	$16.99	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	5.97x	17.40x
EV/Sales	6.97x	17.97x
EV/EBITDA	1,613.51x	31.73x
P/B Ratio	104.09x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.96x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.26x
Revenue & Growth
Revenue (TTM)	$252M	$105M
Revenue Growth (YoY)	222.7%	-33.2%
Forward Rev Growth	41.0%	7.4%
Profitability
Gross Margin (TTM)	95.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-77.0%	-188.5%
Net Margin (TTM)	-87.5%	-155.6%
FCF Margin (TTM)	-87.6%	-198.4%
Net Income (TTM)	$-221M	$-163M
FCF (TTM)	$-221M	$-208M
EPS (TTM)	-$2.48	-$2.15
ROE (TTM)	-37294.0%	-2866.0%
ROA (TTM)	-3911.0%	-2038.0%
ROIC (TTM)	-4756.0%	-2379.0%
Financial Health
Cash	$336M	$45M
Debt	$588M	$105M
Net Cash/Debt	$-252M	$-60M
Current Ratio (TTM)	6.77x	6.39x
Quick Ratio (TTM)	6.32x	6.09x
Debt/Equity (TTM)	38.95x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.40	0.81
52W Performance	3.0%	98.6%
YTD Performance	-20.2%	65.1%
% from 52W High	-33.6%	-19.5%
% from 52W Low	30.8%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.13x
FCF Yield (TTM)	-14.7%	-11.4%
Earnings Yield (TTM)	-14.7%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	135.1	-231.6
EV/GP/RG	0.15	N/A
Ticker research	View SNDX research	View XNCR research